Medical - Healthcare Information Services
Compare Stocks
5 / 10Stock Comparison
PRVA vs CNC vs UNH vs ALHC vs CVS
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
PRVA vs CNC vs UNH vs ALHC vs CVS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $3.01B | $27.13B | $335.60B | $3.73B | $111.40B |
| Revenue (TTM) | $2.25B | $198.10B | $449.71B | $4.26B | $407.90B |
| Net Income (TTM) | $3.08B | $-6.44B | $12.04B | $20M | $2.93B |
| Gross Margin | 7.0% | 14.9% | 18.8% | 9.0% | 13.9% |
| Operating Margin | 1.6% | -3.7% | 4.2% | 0.8% | 1.5% |
| Forward P/E | 68.5x | 16.3x | 20.2x | 140.9x | 12.2x |
| Total Debt | $10M | $18.78B | $78.39B | $338M | $93.59B |
| Cash & Equiv. | $480M | $17.89B | $24.36B | $578M | $8.51B |
PRVA vs CNC vs UNH vs ALHC vs CVS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Privia Health Group… (PRVA) | 100 | 66.1 | -33.9% |
| Centene Corporation (CNC) | 100 | 89.0 | -11.0% |
| UnitedHealth Group … (UNH) | 100 | 92.7 | -7.3% |
| Alignment Healthcar… (ALHC) | 100 | 68.8 | -31.2% |
| CVS Health Corporat… (CVS) | 100 | 114.3 | +14.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PRVA vs CNC vs UNH vs ALHC vs CVS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PRVA ranks third and is worth considering specifically for quality.
- 137.2% margin vs CNC's -3.3%
CNC is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.39, Low D/E 93.6%, current ratio 1.68x
- Lower P/E (16.3x vs 140.9x)
UNH has the current edge in this matchup, primarily because of its strength in long-term compounding.
- 220.6% 10Y total return vs CNC's 81.2%
- 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (3 stocks pay no dividend)
- 3.9% ROA vs CNC's -7.9%, ROIC 9.2% vs -21.6%
ALHC is the clearest fit if your priority is growth exposure.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- 46.1% revenue growth vs CVS's 7.8%
CVS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Beta 0.05, yield 3.1%, current ratio 0.84x
- Beta 0.05 vs PRVA's 1.03
- +34.7% vs CNC's -12.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.1% revenue growth vs CVS's 7.8% | |
| Value | Lower P/E (16.3x vs 140.9x) | |
| Quality / Margins | 137.2% margin vs CNC's -3.3% | |
| Stability / Safety | Beta 0.05 vs PRVA's 1.03 | |
| Dividends | 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +34.7% vs CNC's -12.7% | |
| Efficiency (ROA) | 3.9% ROA vs CNC's -7.9%, ROIC 9.2% vs -21.6% |
PRVA vs CNC vs UNH vs ALHC vs CVS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PRVA vs CNC vs UNH vs ALHC vs CVS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALHC leads in 1 of 6 categories
CNC leads 1 • UNH leads 1 • CVS leads 1 • PRVA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALHC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 200.2x PRVA's $2.2B. PRVA is the more profitable business, keeping 137.2% of every revenue dollar as net income compared to CNC's -3.3%. On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $198.1B | $449.7B | $4.3B | $407.9B |
| EBITDAEarnings before interest/tax | $48M | -$5.9B | $23.2B | $66M | $10.5B |
| Net IncomeAfter-tax profit | $3.1B | -$6.4B | $12.0B | $20M | $2.9B |
| Free Cash FlowCash after capex | -$49.3B | $6.3B | $19.7B | $237M | $7.4B |
| Gross MarginGross profit ÷ Revenue | +7.0% | +14.9% | +18.8% | +9.0% | +13.9% |
| Operating MarginEBIT ÷ Revenue | +1.6% | -3.7% | +4.2% | +0.8% | +1.5% |
| Net MarginNet income ÷ Revenue | +137.2% | -3.3% | +2.7% | +0.5% | +0.7% |
| FCF MarginFCF ÷ Revenue | -21.9% | +3.2% | +4.4% | +5.6% | +1.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +25.8% | +7.1% | +2.0% | +33.3% | +6.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -33.3% | +18.3% | +0.7% | +2.1% | +63.1% |
Valuation Metrics
CNC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 27.9x trailing earnings, UNH trades at a 79% valuation discount to PRVA's 133.3x P/E. On an enterprise value basis, CVS's 13.1x EV/EBITDA is more attractive than ALHC's 77.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.0B | $27.1B | $335.6B | $3.7B | $111.4B |
| Enterprise ValueMkt cap + debt − cash | $2.5B | $28.0B | $389.6B | $3.5B | $196.5B |
| Trailing P/EPrice ÷ TTM EPS | 133.28x | -4.03x | 27.95x | -4932.43x | 62.81x |
| Forward P/EPrice ÷ next-FY EPS est. | 68.48x | 16.29x | 20.19x | 140.93x | 12.19x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 57.62x | — | 16.70x | 77.12x | 13.11x |
| Price / SalesMarket cap ÷ Revenue | 1.42x | 0.14x | 0.75x | 0.94x | 0.28x |
| Price / BookPrice ÷ Book value/share | 3.91x | 1.35x | 3.31x | 20.16x | 1.47x |
| Price / FCFMarket cap ÷ FCF | 18.58x | 6.28x | 20.88x | 32.95x | 14.27x |
Profitability & Efficiency
UNH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-29 for CNC. PRVA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x. On the Piotroski fundamental quality scale (0–9), CNC scores 6/9 vs CVS's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.5% | -28.6% | +11.5% | +11.5% | +3.9% |
| ROA (TTM)Return on assets | +0.9% | -7.9% | +3.9% | +1.8% | +1.1% |
| ROICReturn on invested capital | +9.9% | -21.6% | +9.2% | — | +5.0% |
| ROCEReturn on capital employed | +4.6% | -14.6% | +9.7% | +2.9% | +6.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 0.94x | 0.77x | 1.89x | 1.24x |
| Net DebtTotal debt minus cash | -$470M | $889M | $54.0B | -$240M | $85.1B |
| Cash & Equiv.Liquid assets | $480M | $17.9B | $24.4B | $578M | $8.5B |
| Total DebtShort + long-term debt | $10M | $18.8B | $78.4B | $338M | $93.6B |
| Interest CoverageEBIT ÷ Interest expense | — | -9.03x | 4.71x | 1.27x | 2.11x |
Total Returns (Dividends Reinvested)
Evenly matched — ALHC and CVS each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVS five years ago would be worth $11,700 today (with dividends reinvested), compared to $7,388 for PRVA. Over the past 12 months, CVS leads with a +34.7% total return vs CNC's -12.7%. The 3-year compound annual growth rate (CAGR) favors ALHC at 36.2% vs UNH's -7.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.3% | +31.5% | +10.6% | -9.7% | +10.6% |
| 1-Year ReturnPast 12 months | +2.9% | -12.7% | -3.2% | +17.6% | +34.7% |
| 3-Year ReturnCumulative with dividends | -19.8% | -19.5% | -19.9% | +152.4% | +36.6% |
| 5-Year ReturnCumulative with dividends | -26.1% | -22.0% | -2.6% | -22.7% | +17.0% |
| 10-Year ReturnCumulative with dividends | +4.3% | +81.2% | +220.6% | +5.4% | +3.5% |
| CAGR (3Y)Annualised 3-year return | -7.1% | -7.0% | -7.1% | +36.2% | +11.0% |
Risk & Volatility
CVS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than PRVA's 1.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs ALHC's 76.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.03x | 0.39x | 0.59x | 0.75x | 0.05x |
| 52-Week HighHighest price in past year | $26.51 | $64.15 | $395.52 | $23.87 | $88.63 |
| 52-Week LowLowest price in past year | $18.77 | $25.08 | $234.60 | $11.63 | $58.35 |
| % of 52W HighCurrent price vs 52-week peak | +90.5% | +85.7% | +93.5% | +76.5% | +98.5% |
| RSI (14)Momentum oscillator 0–100 | 55.6 | 83.5 | 75.9 | 37.3 | 69.3 |
| Avg Volume (50D)Average daily shares traded | 901K | 5.8M | 7.9M | 3.6M | 7.4M |
Analyst Outlook
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PRVA as "Buy", CNC as "Buy", UNH as "Buy", ALHC as "Buy", CVS as "Buy". Consensus price targets imply 36.1% upside for ALHC (target: $25) vs -7.2% for CNC (target: $51). For income investors, CVS offers the higher dividend yield at 3.06% vs UNH's 2.35%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $31.67 | $51.00 | $385.43 | $24.83 | $95.20 |
| # AnalystsCovering analysts | 22 | 43 | 52 | 16 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.4% | — | +3.1% |
| Dividend StreakConsecutive years of raises | — | 1 | 25 | — | 0 |
| Dividend / ShareAnnual DPS | — | — | $8.70 | — | $2.67 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.8% | +1.7% | 0.0% | 0.0% |
ALHC leads in 1 of 6 categories (Income & Cash Flow). CNC leads in 1 (Valuation Metrics). 2 tied.
PRVA vs CNC vs UNH vs ALHC vs CVS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PRVA or CNC or UNH or ALHC or CVS a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate Privia Health Group, Inc. (PRVA) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PRVA or CNC or UNH or ALHC or CVS?
On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 27.
9x versus Privia Health Group, Inc. at 133. 3x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PRVA or CNC or UNH or ALHC or CVS?
Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +17.
0%, compared to -26. 1% for Privia Health Group, Inc. (PRVA). Over 10 years, the gap is even starker: UNH returned +220. 6% versus CVS's +3. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PRVA or CNC or UNH or ALHC or CVS?
By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.
05β versus Privia Health Group, Inc. 's 1. 03β — meaning PRVA is approximately 1932% more volatile than CVS relative to the S&P 500. On balance sheet safety, Privia Health Group, Inc. (PRVA) carries a lower debt/equity ratio of 1% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PRVA or CNC or UNH or ALHC or CVS?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PRVA or CNC or UNH or ALHC or CVS?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -3. 4% for Centene Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -3. 9% for CNC. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PRVA or CNC or UNH or ALHC or CVS more undervalued right now?
On forward earnings alone, CVS Health Corporation (CVS) trades at 12.
2x forward P/E versus 140. 9x for Alignment Healthcare, Inc. — 128. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 36. 1% to $24. 83.
08Which pays a better dividend — PRVA or CNC or UNH or ALHC or CVS?
In this comparison, CVS (3.
1% yield), UNH (2. 4% yield) pay a dividend. PRVA, CNC, ALHC do not pay a meaningful dividend and should not be held primarily for income.
09Is PRVA or CNC or UNH or ALHC or CVS better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 1% yield). Both have compounded well over 10 years (CVS: +3. 5%, PRVA: +4. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PRVA and CNC and UNH and ALHC and CVS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PRVA is a small-cap high-growth stock; CNC is a mid-cap high-growth stock; UNH is a large-cap quality compounder stock; ALHC is a small-cap high-growth stock; CVS is a mid-cap income-oriented stock. UNH, CVS pay a dividend while PRVA, CNC, ALHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.